Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-18

Clinical Trial Update: Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute Migraine [Phase 1]

View source ↗

Summary

Phase 1 safety, pharmacokinetic, and tolerability study of the Zecuity patch in adolescents with a history of acute migraine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zecuity (Sumatriptan)

Snippet

Sponsor: NuPathe Inc. | Conditions: Acute Migraine | Phase 1 | Status: COMPLETED